Prevalence and severity of cognitive dysfunction in patients referred for transcatheter aortic valve implantation (TAVI): clinical and cognitive impact at 1 year.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 29 12 2021
accepted: 21 02 2022
pubmed: 12 3 2022
medline: 19 7 2022
entrez: 11 3 2022
Statut: ppublish

Résumé

We estimated the proportion and severity of cognitive disorders in an unselected population of patients referred for transcatheter aortic valve implantation (TAVI). Second, we describe clinical and cognitive outcomes at 1 year. Eligible patients were aged ≥ 70 years, with symptomatic aortic stenosis and an indication for TAVI. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive dysfunction (CD), defined as no CD if score ≥ 26, mild CD if 18-25; moderate CD if 10-18, and severe CD if < 10. We assessed survival and in-hospital complications at 6 months and 1 year. Between June 2019 and October 2020, 105 patients were included; 21 (20%) did not undergo TAVI, and thus, 84 were analyzed; median age 85 years, 53.6% females, median EuroScore 11.5%. Median MoCA score was 22 (19-25); CD was excluded in 18 (21%), mild in 50 (59.5%), moderate in 15 (19%) and severe in 1. Mean MoCA score at follow-up was 21.9(± 4.69) and did not differ significantly from baseline (21.79 (± 4.61), p = 0.73). There was no difference in success rate, in-hospital complications, or death across CD categories. The clinical course of patients with mild or moderate CD is not different at 1 year after TAVI compared to those without cognitive dysfunction.

Identifiants

pubmed: 35275374
doi: 10.1007/s40520-022-02102-2
pii: 10.1007/s40520-022-02102-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1883

Subventions

Organisme : Edwards Lifesciences
ID : THV-I16-102/THV-I18-122

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

d’Arcy JL, Coffey S, Loudon MA (2016) Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J 37:3515–3522. https://doi.org/10.1093/eurheartj/ehw229
doi: 10.1093/eurheartj/ehw229 pubmed: 27354049 pmcid: 5216199
Afilalo J, Lauck, S Kim DH (2017) Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 70:689–700. https://doi.org/10.1016/j.jacc.2017.06.024
doi: 10.1016/j.jacc.2017.06.024 pubmed: 28693934
Afilalo J, Mottillo S, Eisenberg MJ (2012) Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes 5:222–228. https://doi.org/10.1161/CIRCOUTCOMES.111.963157
doi: 10.1161/CIRCOUTCOMES.111.963157 pubmed: 22396586
Okonkwo OC, Cohen RA, Gunstad J (2010) Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease. Cerebrovasc Dis 30:362–373. https://doi.org/10.1159/000319564
doi: 10.1159/000319564
Jutkowitz E, Gozalo P, Trivedi A (2020) The effect of physical and cognitive impairments on caregiving. Med Care 58:601–609. https://doi.org/10.1097/MLR.0000000000001323
doi: 10.1097/MLR.0000000000001323 pubmed: 32287048 pmcid: 7289673
Lowenstern A, Wang TY (2019) Rethinking cognitive impairment in the management of older patients with cardiovascular disease. J Am Heart Assoc 8:e011968. https://doi.org/10.1161/JAHA.119.011968
doi: 10.1161/JAHA.119.011968 pubmed: 30773969 pmcid: 6405686
Vahanian A, Beyersdorf F, Praz F (2021) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. https://doi.org/10.1093/eurheartj/ehab395
doi: 10.1093/eurheartj/ehab395 pubmed: 34529759 pmcid: 8014526
Yanagisawa R, Tanaka M, Yashima F (2018) Frequency and consequences of cognitive impairmentin patients underwent transcatheter aortic valve implantation. Am J Cardiol 122:844–850. https://doi.org/10.1016/j.amjcard.2018.05.026
doi: 10.1016/j.amjcard.2018.05.026 pubmed: 30072128
Ghezzi ES, Ross TJ, Davis D (2020) Meta-analysis of prevalence and risk factors for cognitive decline and improvement after transcatheter aortic valve implantation. Am J Cardiol 127:105–112. https://doi.org/10.1016/j.amjcard.2020.04.023
doi: 10.1016/j.amjcard.2020.04.023 pubmed: 32402486 pmcid: 8376655
Ciesielska N, Sokołowski R, Mazur E (2016) Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis Psychiatr Pol 50:1039–1052. https://doi.org/10.12740/PP/45368
doi: 10.12740/PP/45368 pubmed: 27992895
Nasreddine ZS, Phillips NA, Bédirian V (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
doi: 10.1111/j.1532-5415.2005.53221.x pubmed: 15817019
Angermann S, Baumann M, Steubl D (2017) Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening. PLoS ONE 12:e0184589. https://doi.org/10.1371/journal.pone.0184589
doi: 10.1371/journal.pone.0184589 pubmed: 29016605 pmcid: 5634551
Carson N, Leach L, Murphy KJ (2018) A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry 33:379–388. https://doi.org/10.1002/gps.4756
doi: 10.1002/gps.4756 pubmed: 28731508
Thomann AE, Berres M, Goettel N (2020) Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment. Alz Res Therapy 12:39. https://doi.org/10.1186/s13195-020-00603-8
doi: 10.1186/s13195-020-00603-8
Tu Q-Y, Jin H, Ding B-R (2013) Reliability, validity, and optimal cutoff score of the Montreal Cognitive Assessment (changsha version) in ischemic cerebrovascular disease patients of Hunan province, China. Dement Geriatr Cogn Disord Extra 3:25–36. https://doi.org/10.1159/000346845
doi: 10.1159/000346845
Auffret V, Campelo-Parada F, Regueiro A (2016) Serial changes in cognitive function following transcatheter aortic valve replacement. J Am Coll Cardiol 68:2129–2141. https://doi.org/10.1016/j.jacc.2016.08.046
doi: 10.1016/j.jacc.2016.08.046 pubmed: 27692728
Rudolph JL, Schreiber KA, Culley DJ (2010) Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiol Scand 54:663–677. https://doi.org/10.1111/j.1399-6576.2010.02236.x
doi: 10.1111/j.1399-6576.2010.02236.x pubmed: 20397979 pmcid: 2919360
Rouleau I, Salmon DP, Butters N (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer’s and Huntington’s disease. Brain Cogn 18:70–87. https://doi.org/10.1016/0278-2626(92)90112-y
doi: 10.1016/0278-2626(92)90112-y pubmed: 1543577
Siciliano M, Santangelo G, D’Iorio A (2016) Rouleau version of the Clock Drawing Test: age- and education-adjusted normative data from a wide Italian sample. Clin Neuropsychol 30:1501–1516. https://doi.org/10.1080/13854046.2016.1241893
doi: 10.1080/13854046.2016.1241893 pubmed: 27702066
Genereux P, Piazza N, Alu MC (2021) Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol 77:2717–2746
doi: 10.1016/j.jacc.2021.02.038
Fanning JP, Wesley AJ, Walters DL (2016) Neurological injury in intermediate-risk transcatheter aortic valve implantation. J Am Heart Assoc 5:e004203. https://doi.org/10.1161/JAHA.116.004203
doi: 10.1161/JAHA.116.004203 pubmed: 27849158 pmcid: 5210348
Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548–561. https://doi.org/10.1002/1099-1166(200006)15:6<548::aid-gps242>3.0.co;2-u
doi: 10.1002/1099-1166(200006)15:6<548::aid-gps242>3.0.co;2-u pubmed: 10861923
Wiggins ME, Dion C, Formanski E (2021) Proof of concept: digital clock drawing behaviors prior to transcatheter aortic valve replacement may predict length of hospital stay and cost of care. Explor Med 2:110–121. https://doi.org/10.37349/emed.2021.00036
doi: 10.37349/emed.2021.00036 pubmed: 34263257 pmcid: 8276939
Bobet AS, Brouessard C, Le Tourneau T, Manigold T, de Decker L, Boureau AS (2021) Length of stay in older patients undergoing transcatheter aortic valve replacement: value of a geriatric approach. Gerontology. https://doi.org/10.1159/000518821
doi: 10.1159/000518821 pubmed: 34903687
Ghanem A, Kocurek J, Sinning J-M (2013) Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv 6:615–624. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000429
doi: 10.1161/CIRCINTERVENTIONS.112.000429 pubmed: 24129642
Lansky AJ, Brown D, Pena C (2016) Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI Trial). Am J Cardiol 118:1519–1526. https://doi.org/10.1016/j.amjcard.2016.08.013
doi: 10.1016/j.amjcard.2016.08.013 pubmed: 27645761
Bosch J, O’Donnell M, Swaminathan B (2019= Effects of blood pressure and lipid lowering on cognition: results from the HOPE-3 study. Neurology 92:e1435–e1446. https://doi.org/10.1212/WNL.0000000000007174WNL.0000000000007174[pii]
doi: 10.1212/WNL.0000000000007174WNL.0000000000007174[pii] pubmed: 30814321 pmcid: 6453765
Gluhm S, Goldstein J, Loc K (2013) Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol 26:1–5. https://doi.org/10.1097/WNN.0b013e31828b7d26
doi: 10.1097/WNN.0b013e31828b7d26 pubmed: 23538566 pmcid: 3638088
Schoenenberger AW, Zuber C, Moser A (2016) Evolution of cognitive function after transcatheter aortic valve implantation Circ Cardiovasc Interv 9:e003590. https://doi.org/10.1161/CIRCINTERVENTIONS.116.003590
doi: 10.1161/CIRCINTERVENTIONS.116.003590 pubmed: 27655999
Baran J, Przewłocki T, Podolec J (2021) Assessment of the Willis circle flow changes and the severity of degenerative aortic stenosis and cognitive impairment. Kardiol Pol 79:46–52. https://doi.org/10.33963/KP.15642
doi: 10.33963/KP.15642 pubmed: 33047941
Langa KM, Levine DA (2014) The diagnosis and management of mild cognitive impairment: a clinical review. JAMA 312:2551–2561. https://doi.org/10.1001/jama.2014.13806
doi: 10.1001/jama.2014.13806 pubmed: 25514304 pmcid: 4269302

Auteurs

Charles Monnin (C)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.

Matthieu Besutti (M)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.

Fiona Ecarnot (F)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France. Fiona.ecarnot@univ-fcomte.fr.
EA3920, University of Franche-Comté, 25000, Besancon, France. Fiona.ecarnot@univ-fcomte.fr.

Benoit Guillon (B)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.

Marion Chatot (M)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.

Romain Chopard (R)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.
EA3920, University of Franche-Comté, 25000, Besancon, France.

Mohamed Yahia (M)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.

Nicolas Meneveau (N)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.
EA3920, University of Franche-Comté, 25000, Besancon, France.

François Schiele (F)

Department of Cardiology, University Hospital Besancon, 25000, Besancon, France.
EA3920, University of Franche-Comté, 25000, Besancon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH